195 related articles for article (PubMed ID: 32479008)
21. Effects of a glycine transporter-1 inhibitor and D-serine on MK-801-induced immobility in the forced swimming test in rats.
Kawaura K; Koike H; Kinoshita K; Kambe D; Kaku A; Karasawa J; Chaki S; Hikichi H
Behav Brain Res; 2015 Feb; 278():186-92. PubMed ID: 25300471
[TBL] [Abstract][Full Text] [Related]
22. MK-801-induced hyperlocomotion: differential effects of M100907, SDZ PSD 958 and raclopride.
Martin P; Waters N; Waters S; Carlsson A; Carlsson ML
Eur J Pharmacol; 1997 Sep; 335(2-3):107-16. PubMed ID: 9369362
[TBL] [Abstract][Full Text] [Related]
23. [Establishment and application of a mouse model for drug-induced schizophrenia].
Yan H; Li SL; Su RB; Gong ZH
Yao Xue Xue Bao; 2013 Apr; 48(4):484-8. PubMed ID: 23833933
[TBL] [Abstract][Full Text] [Related]
24. Effects of beta-hydroxybutyrate administration on MK-801-induced schizophrenia-like behaviour in mice.
Kraeuter AK; Mashavave T; Suvarna A; van den Buuse M; Sarnyai Z
Psychopharmacology (Berl); 2020 May; 237(5):1397-1405. PubMed ID: 31993694
[TBL] [Abstract][Full Text] [Related]
25. Differential effects of antipsychotics on hippocampal presynaptic protein expressions and recognition memory in a schizophrenia model in mice.
Ozdemir H; Ertugrul A; Basar K; Saka E
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Oct; 39(1):62-8. PubMed ID: 22640753
[TBL] [Abstract][Full Text] [Related]
26. A two-hit model: behavioural investigation of the effect of combined neonatal MK-801 administration and isolation rearing in the rat.
Lim AL; Taylor DA; Malone DT
J Psychopharmacol; 2012 Sep; 26(9):1252-64. PubMed ID: 22361477
[TBL] [Abstract][Full Text] [Related]
27. Effect of clozapine on locomotor activity and anxiety-related behavior in the neonatal mice administered MK-801.
Pınar N; Akillioglu K; Sefil F; Alp H; Sagir M; Acet A
Bosn J Basic Med Sci; 2015 Aug; 15(3):74-9. PubMed ID: 26295298
[TBL] [Abstract][Full Text] [Related]
28. Mice with reduced NMDA receptor expression display behaviors related to schizophrenia.
Mohn AR; Gainetdinov RR; Caron MG; Koller BH
Cell; 1999 Aug; 98(4):427-36. PubMed ID: 10481908
[TBL] [Abstract][Full Text] [Related]
29. A competitive antagonist of NMDA receptors CGP 40116 attenuates experimental symptoms of schizophrenia evoked by MK-801.
Zajaczkowski W; Czyrak A; Wedzony K
Pol J Pharmacol; 2003; 55(5):703-11. PubMed ID: 14704466
[TBL] [Abstract][Full Text] [Related]
30. Suppressive effect of clozapine but not haloperidol on the increases of neuropeptide-degrading enzymes and glial cells in MK-801-treated rat brain regions.
Arif M; Chikuma T; Ahmed MM; Yoshida S; Kato T
Neurosci Res; 2007 Feb; 57(2):248-58. PubMed ID: 17141345
[TBL] [Abstract][Full Text] [Related]
31. Behavioral evidence for modulation by sigma ligands of (+)MK-801-induced hyperlocomotion in monoamine-depleted mice.
Okuyama S; Imagawa Y; Tomisawa K
Neuropharmacology; 1996 Apr; 35(4):467-74. PubMed ID: 8793909
[TBL] [Abstract][Full Text] [Related]
32. Systemic administration of MK-801 produces an abnormally persistent latent inhibition which is reversed by clozapine but not haloperidol.
Gaisler-Salomon I; Weiner I
Psychopharmacology (Berl); 2003 Apr; 166(4):333-42. PubMed ID: 12599023
[TBL] [Abstract][Full Text] [Related]
33. Decreased glial reactivity could be involved in the antipsychotic-like effect of cannabidiol.
Gomes FV; Llorente R; Del Bel EA; Viveros MP; López-Gallardo M; Guimarães FS
Schizophr Res; 2015 May; 164(1-3):155-63. PubMed ID: 25680767
[TBL] [Abstract][Full Text] [Related]
34. Role of different monoamine receptors controlling MK-801-induced release of serotonin and glutamate in the medial prefrontal cortex: relevance for antipsychotic action.
López-Gil X; Artigas F; Adell A
Int J Neuropsychopharmacol; 2009 May; 12(4):487-99. PubMed ID: 18752722
[TBL] [Abstract][Full Text] [Related]
35. Predictive validity of a MK-801-induced cognitive impairment model in mice: implications on the potential limitations and challenges of modeling cognitive impairment associated with schizophrenia preclinically.
Brown JW; Rueter LE; Zhang M
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Mar; 49():53-62. PubMed ID: 24269664
[TBL] [Abstract][Full Text] [Related]
36. The role of serotonin in the NMDA receptor antagonist models of psychosis and cognitive impairment.
Meltzer HY; Horiguchi M; Massey BW
Psychopharmacology (Berl); 2011 Feb; 213(2-3):289-305. PubMed ID: 21212939
[TBL] [Abstract][Full Text] [Related]
37. The Influence of the CB1 Receptor Ligands on the Schizophrenia-Like Effects in Mice Induced by MK-801.
Kruk-Slomka M; Budzynska B; Slomka T; Banaszkiewicz I; Biala G
Neurotox Res; 2016 Nov; 30(4):658-676. PubMed ID: 27577742
[TBL] [Abstract][Full Text] [Related]
38. Chronic treatment with caffeine blunts the hyperlocomotor but not cognitive effects of the N-methyl-D-aspartate receptor antagonist MK-801 in mice.
Dall'Igna OP; Da Silva AL; Dietrich MO; Hoffmann A; de Oliveira RV; Souza DO; Lara DR
Psychopharmacology (Berl); 2003 Mar; 166(3):258-63. PubMed ID: 12589526
[TBL] [Abstract][Full Text] [Related]
39. The influence of N-desmethylclozapine and clozapine on recognition memory and BDNF expression in hippocampus.
Ertuğrul A; Ozdemir H; Vural A; Dalkara T; Meltzer HY; Saka E
Brain Res Bull; 2011 Feb; 84(2):144-50. PubMed ID: 21134422
[TBL] [Abstract][Full Text] [Related]
40. Maslinic acid ameliorates NMDA receptor blockade-induced schizophrenia-like behaviors in mice.
Jeon SJ; Kim E; Lee JS; Oh HK; Zhang J; Kwon Y; Jang DS; Ryu JH
Neuropharmacology; 2017 Nov; 126():168-178. PubMed ID: 28899728
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
